Columbia Neurologist Lawrence S. Honig, MD, PhD, talks about a small early trial study that used transcranial magnetic stimulation (TMS) to target a key brain network that stores memories
Columbia Physician-Scientist Philip L. De Jager, MD, PhD and Neuroscientist Vilas Menon, PhD led an innovative study that suggests new ways to prevent the development of Alzheimer’s Disease.
Columbia Neuroscientist Caghan Kizil, PhD led a study on how the ABCA7 gene, common in many racial & ethnic groups, increases the probability of developing Alzheimer's disease.
Other researchers are not convinced that these biomarkers vary by race, primarily because so little Alzheimer’s research has been conducted on Black and Latinx people.
It is well established that people who had fewer opportunities to receive education when they were children are at higher risk for Alzheimer’s disease later in life, noted Dr. Jennifer Manly
During March, Women’s History Month, CUMC is sharing the stories of some of the many women who are spearheading innovation through research, patient care, and education.
The American Academy of Neurology (AAN) has honored Dr. James Noble, associate professor of neurology in the Division of Aging and Dementia, with a 2021 A. B. Baker Teacher Recognition Award.
It is difficult to isolate large quantities of microglia from human brain. That’s why scientists still know little about the different ways these cells rear up in health and disease.
Decades before the first symptoms of Alzheimer’s appear, the brain’s neurons start secreting tau proteins, one of the first changes known to occur in the course of the disease.